Erasca

Erasca

Erasca

Erasca is a developer of oncology drugs intended provide precision oncology options.
Founded
2018
Raised
$300M
Follow us
Alexa global traffic share
Latest funding Show all
$36,000,000
Venture capital (Series B) - 2020
Partner Fund Management (PFM) OrbiMed Partner Fund Management
$200,000,000
Venture capital (Series B) - 2020
ARCH Venture Partners Invus EDB Investments +6
Team Size
1–10
Employees
$36,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Erasca Completes $36M Extension of Series B Financing

Xconomy

Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More

$200,000,000 Venture capital (Series B)
thetechstartups , Pulse 2.0

Biotech startup Erasca raises $200 million Series B funding to fight cancer

DealStreetAsia , Crunchbase News , FinSMEs , +1

Singapore’s EDBI joins US oncology startup Erasca’s $200m Series B round

$22,000,000 Venture capital (Series A)
FinSMEs

Erasca Raises Series A Extension; Round Totals $64M

$42,000,000 Venture capital (Series A)
StartupWorld

Erasca Launches With $42 Million To Support Erasing Cancer